BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/14/2021 5:28:58 AM | Browse: 503 | Download: 981
 |
Received |
|
2021-03-26 02:43 |
 |
Peer-Review Started |
|
2021-03-26 02:47 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-05-06 00:20 |
 |
Revised |
|
2021-05-21 07:40 |
 |
Second Decision |
|
2021-11-26 03:32 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-11-28 08:13 |
 |
Articles in Press |
|
2021-11-28 08:13 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-11-22 00:07 |
 |
Typeset the Manuscript |
|
2021-11-29 02:29 |
 |
Publish the Manuscript Online |
|
2021-12-14 05:28 |
ISSN |
1949-8454 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Neurosciences |
Manuscript Type |
Minireviews |
Article Title |
Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Yuka Ikeda, Nozomi Nagase, Ai Tsuji, Yasuko Kitagishi and Satoru Matsuda |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Satoru Matsuda, MD, PhD, Professor, Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan. smatsuda@cc.nara-wu.ac.jp |
Key Words |
Alzheimer’s disease; Cognitive disorder; Dementia; Glucagon-like peptide-1; Dipeptidyl peptidase-4; Mammalian/mechanistic target of rapamycin |
Core Tip |
Disorders of mammalian/mechanistic target of rapamycin (mTOR) signaling pathways are related to Alzheimer’s disease (AD). Although further studies for mTOR, glucagon-like peptide-1, and dipeptidyl-peptidase-4 signaling are needed, they seem to be a promising approach for innovative AD-treatments. |
Publish Date |
2021-12-14 05:28 |
Citation |
Ikeda Y, Nagase N, Tsuji A, Kitagishi Y, Matsuda S. Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease. World J Biol Chem 2021; 12(6) 104-113 |
URL |
https://www.wjgnet.com/1949-8454/full/v12/i6/104.htm |
DOI |
https://dx.doi.org/10.4331/wjbc.v12.i6.104 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345